Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
AbbVie Raises Offer for Shire to $51.5 Billion
Bloomberg
Tue, 07/8/14 - 08:18 am
Shire
AbbVie
M&A
Ackman proposes new slate of Allergan directors amid takeover war
Marketwatch
Mon, 07/7/14 - 07:32 pm
Bill Ackman
Allergan
M&A
Valeant Pharmaceuticals
Omega Pharma Exploring Sale of More Than $4 Billion
Bloomberg
Mon, 07/7/14 - 03:33 pm
Omega Pharma
M&A
OTC
consumer health
Where's the U.K. outrage over AbbVie's pursuit of Shire?
Fierce Biotech
Mon, 07/7/14 - 11:05 am
UK
M&A
Shire
AbbVie
AstraZeneca
Pfizer
AbbVie Will Make Another Attempt To Buy Shire PLC
Motley Fool
Mon, 07/7/14 - 10:37 am
AbbVie
Shire
M&A
AbbVie battle for Shire: why this time it's different
The Telegraph, UK
Sun, 07/6/14 - 10:16 am
AbbVie
Shire
M&A
Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions
Seeking Alpha
Thu, 07/3/14 - 09:59 am
Pfizer
M&A
Gilead Sciences
AstraZeneca
Celgene
AbbVie presses case for Shire deal in discreet roadshow
Yahoo/Reuters
Thu, 07/3/14 - 09:40 am
AbbVie
Shire
M&A
AbbVie CEO visited Shire holders, urged them to pressure company, FT says
The Fly on the Wall
Wed, 07/2/14 - 04:32 pm
Shire
AbbVie
M&A
Richard Gonzalez
Takeda's chief-in-waiting sees big M&A in the drugmaker's future
Fierce Biotech
Wed, 07/2/14 - 01:13 pm
Takeda
M&A
Christophe Weber
Roche's Deal Should Sound Early Warning
WSJ Online
Wed, 07/2/14 - 09:53 am
Roche
M&A
Seragon
breast cancer
Investor Ackman hires Credit Suisse for Allergan bid -source
Yahoo/Reuters
Wed, 07/2/14 - 09:32 am
Bill Ackman
Allergan
Valeant Pharmaceuticals
M&A
Roche to buy U.S. biotech firm Seragon for $725 million
Yahoo/Reuters
Wed, 07/2/14 - 02:45 am
Roche
M&A
Seragon
Allergan readies defense as it fights Valeant for votes
Yahoo/Reuters
Wed, 07/2/14 - 12:02 am
Valeant Pharmaceuticals
Allergan
M&A
Should AstraZeneca Buy MannKind?
Motley Fool
Tue, 07/1/14 - 11:55 pm
MannKind
diabetes
Afrezza
M&A
AstraZeneca
Actavis’s Dealmaking New CEO Has ‘Zero Plans’ for Sale
Bloomberg
Tue, 07/1/14 - 01:30 pm
Actavis
M&A
Pharma CEOs
Brent Saunders
Actavis represents good takeover alternative for Pfizer, says Leerink
Yahoo/Fly on the Wall
Tue, 07/1/14 - 12:23 pm
Pfizer
Actavis
M&A
Forest Labs
AstraZeneca
DEALTALK-Allergan readies defense as it fights Valeant for votes
Reuters
Tue, 07/1/14 - 11:21 am
Allergan
Valeant Pharmaceuticals
M&A
Actavis plc completes Forest Laboratories acquisition
Reuters
Tue, 07/1/14 - 11:19 am
Actavis
Forest Labs
M&A
Why Merck Should Buy Inovio, Seattle Genetics, or MannKind
Motley Fool
Tue, 07/1/14 - 10:37 am
Merck
M&A
Inovio
Seattle Genetics
MannKind
Pages
« first
‹ previous
…
192
193
194
195
196
197
198
199
200
…
next ›
last »